Brenda Yuan
About Brenda Yuan
Brenda Yuan is a Clinical Scientist specializing in Cell Therapy at Bristol Myers Squibb in Summit, New Jersey. She holds a Doctor of Pharmacy (PharmD) degree from Rutgers University and has diverse experience in clinical, operational, and financial roles within the pharmaceutical industry.
Current Role At Bristol Myers Squibb
Brenda Yuan is currently a Clinical Scientist in the Cell Therapy division at Bristol Myers Squibb. She has been in this role since July 2019, based in Summit, New Jersey, United States. Her responsibilities likely include overseeing clinical trials, ensuring regulatory compliance, and contributing to the development of innovative cell therapies. With a robust background in pharmaceutical sciences and hands-on experience, she plays a crucial role in advancing cell-based treatments for patients.
Previous Roles and Experience
Brenda Yuan has an extensive background in the pharmaceutical sector, highlighted by several key positions. She served as Adjunct Faculty at Rutgers University from 2019 to 2021 in New Brunswick, NJ. Before that, she was a Cancer Therapy Evaluation Program (CTEP) Extern at The National Institutes of Health in 2018, located in Rockville, MD. Prior to her current role, she was a Clinical Operations Intern at Bristol Myers Squibb from 2017 to 2018 in Lawrenceville, NJ, and a Specialty Pharmacy Intern at Walgreens from 2017 to 2020 in New Brunswick, NJ. This diverse experience has equipped her with a comprehensive skill set in both clinical and operational roles.
Education and Expertise
Brenda Yuan holds a Doctor of Pharmacy (PharmD) degree from Rutgers University. This advanced educational background in pharmacy provides her with a solid foundation in pharmaceutical sciences, clinical practices, and patient care. Her rigorous academic training complements her professional experience in various aspects of the pharmaceutical industry, including cell therapy, cancer therapy evaluation, and specialty pharmacy.
Internship Experience
During her career, Brenda Yuan has completed several internships that have broadened her expertise in the pharmaceutical industry. These include a tangible role in cancer therapy evaluation at The National Institutes of Health in 2018. Additionally, she worked as a Finance Intern at WBB Securities LLC from 2016 to 2017, which provided her with crucial insights into health economics and financial operations within the pharmaceutical sector. Brenda also gained experience in bioanalytical sciences through an internship at Eli Lilly and Company in 2015.
Work at Janssen Pharmaceuticals
In 2016, Brenda Yuan interned in Health Economics and Outcomes Research at The Janssen Pharmaceutical Companies of Johnson & Johnson in Titusville, NJ. This role likely involved assessing the economic and clinical outcomes of healthcare products and contributing valuable research to support product development and market access strategies.